SG11202106356QA - An optimized acceptor splice site module for biological and biotechnological applications - Google Patents

An optimized acceptor splice site module for biological and biotechnological applications

Info

Publication number
SG11202106356QA
SG11202106356QA SG11202106356QA SG11202106356QA SG11202106356QA SG 11202106356Q A SG11202106356Q A SG 11202106356QA SG 11202106356Q A SG11202106356Q A SG 11202106356QA SG 11202106356Q A SG11202106356Q A SG 11202106356QA SG 11202106356Q A SG11202106356Q A SG 11202106356QA
Authority
SG
Singapore
Prior art keywords
biological
splice site
acceptor splice
site module
biotechnological applications
Prior art date
Application number
SG11202106356QA
Other languages
English (en)
Inventor
Stylianos Michalakis
Martin Biel
Elvir Becirovic
Original Assignee
Vigeneron Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vigeneron Gmbh filed Critical Vigeneron Gmbh
Publication of SG11202106356QA publication Critical patent/SG11202106356QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/33—Alteration of splicing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • C12N2840/445—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor for trans-splicing, e.g. polypyrimidine tract, branch point splicing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202106356QA 2018-12-20 2019-12-19 An optimized acceptor splice site module for biological and biotechnological applications SG11202106356QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18214415 2018-12-20
PCT/EP2019/086454 WO2020127831A1 (fr) 2018-12-20 2019-12-19 Module de site accepteur d'épissage optimisé pour applications biologiques et biotechnologiques

Publications (1)

Publication Number Publication Date
SG11202106356QA true SG11202106356QA (en) 2021-07-29

Family

ID=64755152

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106356QA SG11202106356QA (en) 2018-12-20 2019-12-19 An optimized acceptor splice site module for biological and biotechnological applications

Country Status (10)

Country Link
US (1) US20220160898A1 (fr)
EP (1) EP3898996A1 (fr)
JP (1) JP2022515606A (fr)
KR (1) KR20210125472A (fr)
CN (1) CN113474460A (fr)
AU (1) AU2019406702A1 (fr)
CA (1) CA3122909A1 (fr)
IL (1) IL284021A (fr)
SG (1) SG11202106356QA (fr)
WO (1) WO2020127831A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4182467A1 (fr) * 2020-07-14 2023-05-24 Abeona Therapeutics Inc. Vecteurs viraux adéno-associés recombinés pour la délivrance de gènes multiples
WO2022170058A1 (fr) * 2021-02-05 2022-08-11 University Of Massachusetts Système d'éditeur primaire pour édition génomique in vivo

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US20030077754A1 (en) * 1995-12-15 2003-04-24 Mitchell Lloyd G. Methods and compositions for use in spliceosome mediated RNA trans-splicing
US6436707B1 (en) * 1998-03-27 2002-08-20 Lexicon Genetics Incorporated Vectors for gene mutagenesis and gene discovery
JP2009000120A (ja) * 1998-08-13 2009-01-08 Virxsys Corp スプライソソーム媒介ｒｎａトランス−スプライシングにおける使用のための方法及び組成物
JP2002538770A (ja) 1998-11-10 2002-11-19 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル ウイルスベクターとその製造及び投与の方法
GB9906615D0 (en) * 1999-03-22 1999-05-19 Oxford Biomedica Ltd Vector
EP1485397A4 (fr) * 2002-02-25 2005-05-25 Intronn Inc Imagerie de l'expression genique mediee par trans-epissage
US7968334B2 (en) 2004-01-23 2011-06-28 Virxsys Corporation Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
EP2486136B1 (fr) 2009-10-08 2016-03-30 Association Institut de Myologie Molécules d'acide nucléique et procédés d'échange d'un ou de plusieurs exons par trans-épissage
EP2742128A4 (fr) 2011-08-12 2015-03-18 Virxsys Corp Compositions et procédés pour l'induction de l'apoptose
WO2013075008A1 (fr) 2011-11-16 2013-05-23 University Of Florida Research Foundation Inc. Systèmes de vecteur double aav pour une thérapie génique
EP2986635B1 (fr) * 2013-04-18 2018-10-03 Fondazione Telethon Administration efficace de grands gènes par des vecteurs aav doubles
EP3697896A1 (fr) 2017-10-16 2020-08-26 Vigeneron GmbH Vecteurs aav

Also Published As

Publication number Publication date
JP2022515606A (ja) 2022-02-21
KR20210125472A (ko) 2021-10-18
CA3122909A1 (fr) 2020-06-25
CN113474460A (zh) 2021-10-01
AU2019406702A1 (en) 2021-06-10
WO2020127831A1 (fr) 2020-06-25
IL284021A (en) 2021-08-31
US20220160898A1 (en) 2022-05-26
EP3898996A1 (fr) 2021-10-27

Similar Documents

Publication Publication Date Title
EP3580597A4 (fr) Optique, dispositif et système d'essai
SG11202008115UA (en) Waveguide element and waveguide stack for display applications
EP3493194A4 (fr) Module de rétroéclairage et procédé de commande associé et dispositif d'affichage et procédé d'attaque associé
EP3373058A4 (fr) Dispositif d'entraînement de lentille, et module de caméra et instrument optique le comprenant
EP3508124A4 (fr) Dispositif de mesure biologique et procédé de mesure biologique
EP3346312A4 (fr) Module de balayage optique et dispositif de commande de balayage optique
DK2531880T3 (da) Fokuseringsmetoder og optiske systemer samt anordninger dermed
EP3133440A4 (fr) Module de caméra et instrument optique
EP3591454A4 (fr) Module optique et dispositif de mesure de distance
GB201710855D0 (en) Backlight module and display device
IL284021A (en) An optimized acceptor splice site module for biological and biotechnological applications
EP3462234A4 (fr) Module d'affichage de rétroéclairage de type direct et dispositif d'affichage
EP3744823A4 (fr) Module de palier, dispositif de chargement d'acide nucléique et application
EP3902000A4 (fr) Module de rétroéclairage
EP3693781A4 (fr) Dispositif de microscope à fluorescence et système de microscope à fluorescence
EP3287690A4 (fr) Module de rétroéclairage et dispositif d'affichage
EP3780299A4 (fr) Module laser et dispositif laser
EP3567407A4 (fr) Module de rétroéclairage, module d'affichage et dispositif d'affichage
EP3516441A4 (fr) Système de visualisation personnalisé pour un dispositif optique
EP3711897A4 (fr) Dispositif d'assemblage et procédé d'assemblage d'un ensemble optique
EP3534552A4 (fr) Dispositif de dérivation/couplage optique et procédé de dérivation/couplage optique
EP3731353A4 (fr) Module laser et système laser
EP3786662A4 (fr) Dispositif de télémétrie et module de télémétrie
EP3410180A4 (fr) Dispositif de rétroéclairage à cristaux liquides
EP3607373A4 (fr) Module de terminaison et d'épissure optique